Legislator Case Law & Legislation
2012_si_135 IE

S.I. No. 135/2012 - Clotting Factor Concentrates and Other Biological Products Act 2012 (Commencement) Order 2012.

3 Articles / Provisions · Ireland
Open official source Machine-readable Markdown (.md)

Statutory Text (3 Articles)

ISB SI

1. This Order may be cited as the Clotting Factor Concentrates and Other Biological Products Act 2012 (Commencement) Order 2012.

ISB SI

2. 30 April 2012 is appointed as the day on which the

Clotting Factor Concentrates and Other Biological Products Act 2012

(No. 8 of 2012) comes into operation.

GIVEN under my Official Seal,

17 April 2012.

JAMES REILLY,

Minister for Health.

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation)

This Order provides for the commencement of the

Clotting Factor Concentrates and Other Biological Products Act 2012

(No. 8 of 2012).

This Act transfers responsibility for the procurement of the national stock of clotting factor concentrates and other biological medicinal products, used in the treatment of haemophilia and other coagulation, congenital or acquired disorders, from the Irish Blood Transfusion Service to St James’s Hospital.

ISB SI

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of

1

st May

, 2012.

I, JAMES REILLY, Minister for Health, in exercise of the powers conferred on me by

section 4

(2) of the

Clotting Factor Concentrates and Other Biological Products Act 2012

(No. 8 of 2012), hereby order as follows

Need to analyze how this provision applies to your matter?

Cross-reference this statute against case law, commentaries, and related legislative provisions inside Legislator AI.

Open in Legislator →